Skip to content

PRImary care Streptococcal Management study (PRISM) Rapid tests for streptococcal sore throat

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN32027234
Enrollment
2026
Registered
2007-02-27
Start date
2006-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Respiratory Tract Infections (LRTI) Respiratory Lower Respiratory Tract Infections

Interventions

This study is in two phases: Phase I is a validation and development phase and will include five components: 1. A clinical study to determine the ease of use and overall performance in clinical sett
OSOM Ultra Strep A
Clearview Exact Test
and IMI Test Pack plus Strep A). Variation in performance due to sampling bias will be assessed by in vitro studies, using standard antigen loads of three group A streps and controls. The choice of RA

Sponsors

University of Southampton (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Phase 1: Adults/children aged 5 and over presenting with acute sore throat ( 2 weeks or less; and with some abnormality of examination of the throat ? i.e. erythema and/or pus). Phase 2: . Previously well subjects aged 3 years and over with acute illness (2 weeks or less), presenting with sore throat as the main symptom, with an abnormal examination of the pharynx.

Exclusion criteria

Exclusion criteria: Phase 1: 1. Other non infective causes of sore throat (e.g. apthous ulceration, candida, drugs) 2. Unable to consent (e.g. dementia, uncontrolled psychosis) Phase 2: 1. Quinsy, previous rheumatic fever, glomerulonephritis. 2. Serious chronic disorders where antibiotics are needed (e.g. cystic fibrosis, valvular heart disease), or mental health problems (e.g. learning difficulties - unable to complete outcome measures).

Design outcomes

Primary

MeasureTime frame
Phase 1: Ease of use and performance in clinical setting of 5 RADTs Phase 2: Diary scores; duration of illness

Secondary

MeasureTime frame
Phase 2: 1. Antibiotic use 2. Side effects 3. Medicalistion of illness

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 21, 2026